GENEURO SA

Patent Applications and Registrations

Patent applications and USPTO patent grants for GENEURO SA.The latest application filed is for "anti-herv-k envelope antibody and uses thereof".

Company Profile

7.17.15

GENEURO SA - Plan-les-Oates CH
Geneuro SA - Plan-les-Ouates N/A CH
GENEURO S.A. - Plan-les-Ouates CH
GENEURO SA - Plan-Les-Ouales CH
Geneuro SA - Plan-Le-Ouates CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis Grant 10,981,977 - Perron , et al. April 20, 2	2021-04-20
Antiretroviral drug targeting human endogenous retrovirus Grant 10,894,820 - Perron , et al. January 19, 2	2021-01-19
Anti-herv-k Envelope Antibody And Uses Thereof App 20200308258 - PERRON; Herve ; et al.	2020-10-01
Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein Grant 10,752,675 - Perron , et al. A	2020-08-25
Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody Grant 10,723,787 - Perron , et al.	2020-07-28
Anti-herv-k Envelope Antibody And Uses Thereof App 20190345232 - PERRON; Herve ; et al.	2019-11-14
Antiretroviral Drug Targeting Human Endogenous Retrovirus App 20190263895 - Perron; Herve ; et al.	2019-08-29
Therapeutic use of specific ligand in MSRV associated diseases Grant 10,059,758 - Bernard , et al. August 28, 2	2018-08-28
Compounds For Treating The Remyelination Blockade In Diseases Associated With The Expression Of Herv-w Envelope Protein App 20180066040 - PERRON; Herve ; et al.	2018-03-08
Therapeutic Use Of Specific Ligand In Msrv Associated Diseases App 20180057569 - BERNARD; Corinne ; et al.	2018-03-01
Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein Grant 9,840,550 - Perron , et al. December 12, 2	2017-12-12
Therapeutic use of specific ligand in MSRV associated diseases Grant 9,815,888 - Bernard , et al. November 14, 2	2017-11-14
Therapeutic Use Of Specific Ligand In Msrv Associated Diseases App 20170107274 - BERNARD; Corinne ; et al.	2017-04-20
Antiretroviral Drug Targeting Human Endogenous Retrovirus App 20170101461 - Perron; Herve ; et al.	2017-04-13
Therapeutic use of specific ligand in MSRV associated diseases Grant 9,550,824 - Bernard , et al. January 24, 2	2017-01-24
Compounds For Treating The Remyelination Blockade In Diseases Associated With The Expression Of Herv-w Envelope Protein App 20150218256 - Perron; Herve ; et al.	2015-08-06
Therapeutic Use Of Specific Ligand In Msrv Associated Diseases App 20140220026 - BERNARD; Corinne ; et al.	2014-08-07
Therapeutic use of specific ligand in MSRV associated diseases Grant 8,715,656 - Bernard , et al. May 6, 2	2014-05-06
Therapeutic Use Of Specific Ligand In Msrv Associated Diseases App 20110243962 - Bernard; Corinne ; et al.	2011-10-06
Pharmaceutical Composition Containing Antibodies Directed Against The Herv-w Envelope App 20100074894 - Perron; Herve	2010-03-25

Company Registrations

NCAGE Code	SGSX0	GENEURO SA
CAGE Code	SGSX0	GENEURO SA
S.A.M. Registration	SGSX0 [483281742]	GENEURO SA

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.